Login

Consolidated Balance Sheets

In millions of USD, except per-share amounts
Q3 FY2023
As of Sep 30, 2023
Q2 FY2023
As of Jun 30, 2023
Q1 FY2023
As of Mar 31, 2023
Q4 FY2022
As of Dec 31, 2022
Q3 FY2022
As of Sep 30, 2022
Q2 FY2022
As of Jun 30, 2022
Q1 FY2022
As of Mar 31, 2022
Q4 FY2021
As of Dec 31, 2021
Q3 FY2021
As of Sep 30, 2021
Q2 FY2021
As of Jun 30, 2021
Q1 FY2021
As of Mar 31, 2021
Cash
ASSETS
Cash
Accounts receivable, net
Employee retention tax credit
Contract assets
Inventory
Prepaid expenses
Others assets
Content asset, net
Prepaid expenses and other assets
Total Current Assets
Investments held in Trust Account
Restricted cash
Property, equipment and leasehold improvements, net
Operating lease right-of-use assets
Intangible assets, net
Other long-term assets
TOTAL ASSETS
LIABILITIES, MEZZANINE EQUITY AND STOCKHOLDERS’ EQUITY
Accounts payable and accrued expenses
Due to related party
Short-term debt
Contract liabilities
Operating lease liabilities, current
Other current liabilities
Total Current Liabilities
Warrant liability
Long-term debt, net of discounts (Note 7)
Other long-term liabilities
Long-term debt, net of discounts (Note 5)
Warrant liabilities
Operating lease liabilities, non-current
Total Liabilities
Class A Common stock subject to possible redemption; 17,250,000 shares (at redemption value of $10.00 per share)
MEZZANINE EQUITY:
Series A preferred stock, $0.00001 par value, 3,545,529 shares authorized at June 30, 2023 and 2022, respectively, zero share shares issued and outstanding at June 30, 2023 and 2022.
Series A preferred stock, $0.00001 par value, 3,545,529 shares authorized at September 30, 2023 and 2022, respectively, zero share shares issued and outstanding at September 30, 2023 and 2022.
Common stock, $0.0001 par value at March 31, 2023 and December 31, 2022, respectively; 500,000,000 and 500,000,000 shares of common stock authorized at March 31, 2023 and December 31, 2022, respectively; 74,046,058 and 71,551,887 shares of common stock issued and outstanding at March 31, 2023 and December 31, 2022, respectively
Common stock, $0.0001 par value at September 30, 2023 and December 31, 2022, respectively; 500,000,000 and 500,000,000 shares of common stock authorized at September 30, 2023 and December 31, 2022, respectively; 75,688,236 and 71,511,887 shares of common stock issued and outstanding at September 30, 2023 and December 31, 2022 respectively
Class A common stock
Class B common stock
Total common stock, $0.0001 par value at September 30, 2023 and December 31, 2022, respectively; 500,000,000 and 500,000,000 shares of common stock authorized at September 30, 2023 and December 31, 2022, respectively; 75,688,236 and 71,511,887 shares of common stock issued and outstanding at September 30, 2023 and December 31, 2022 respectively
Class B Common stock, $0.0001 par value; 10,000,000 shares authorized; 4,312,500 shares issued and outstanding
Additional paid-in capital
Accumulated deficit
Stockholders’ Equity
Class A common stock
Class B common stock
Total Stockholders’ Equity
TOTAL LIABILITIES, MEZZANINE EQUITY, AND STOCKHOLDERS’ EQUITY

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support